Found: 22
Select item for more details and to access through your institution.
Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: Results of the AFR04 study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 1, p. 1, doi. 10.1002/ajh.23330
- By:
- Publication type:
- Article
Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells.
- Published in:
- Cellular Microbiology, 2007, v. 9, n. 6, p. 1412, doi. 10.1111/j.1462-5822.2006.00881.x
- By:
- Publication type:
- Article
CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S335, doi. 10.1016/S2152-2650(21)01784-5
- By:
- Publication type:
- Article
CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S336, doi. 10.1016/S2152-2650(21)01785-7
- By:
- Publication type:
- Article
Poster: CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01412-9
- By:
- Publication type:
- Article
Poster: CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01409-9
- By:
- Publication type:
- Article
Combination of Asciminib+Nilotinib or Asciminib+Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.236
- By:
- Publication type:
- Article
Efficacy and Safety of Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor Targeting the Myristoyl-Binding Site, in Patients with Chronic Myeloid Leukemia (CML) Carrying the T315I Mutation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S289, doi. 10.1016/j.clml.2019.07.234
- By:
- Publication type:
- Article
A Multicenter, Randomized Phase 3 Study of Asciminib (ABL001) vs Bosutinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 TKIs.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S286, doi. 10.1016/j.clml.2019.07.230
- By:
- Publication type:
- Article
Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S287, doi. 10.1016/j.clml.2019.07.231
- By:
- Publication type:
- Article
Clinical Development of Asciminib (ABL001): A Randomized Phase 3 Study of Asciminib vs Bosutinib in Patients with Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S223, doi. 10.1016/j.clml.2018.07.094
- By:
- Publication type:
- Article
Oral Asciminib (ABL001) vs Bosutinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Received ≥ 2 Prior Tyrosine Kinase Inhibitors (TKIs): A Multicenter, Open-Label, Randomized, Phase 3 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S315, doi. 10.1016/j.clml.2017.07.116
- By:
- Publication type:
- Article
A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.
- Published in:
- Transfusion, 2013, v. 53, n. 3, p. 564, doi. 10.1111/j.1537-2995.2012.03744.x
- By:
- Publication type:
- Article
Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 248, doi. 10.1111/j.1365-2141.2007.06562.x
- By:
- Publication type:
- Article
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6247, doi. 10.1007/s00432-022-04562-5
- By:
- Publication type:
- Article
Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 4976, doi. 10.1002/cam4.2371
- By:
- Publication type:
- Article
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 393, doi. 10.1111/bjh.17654
- By:
- Publication type:
- Article
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 337, doi. 10.1111/bjh.16083
- By:
- Publication type:
- Article
Diagnostic et gestion des effets secondaires pleuropulmonaires des inhibiteurs de tyrosine kinase Recommandations du Groupe français pour la leucémie myéloïde chronique.
- Published in:
- Hematologie, 2018, v. 24, n. 2, p. 134, doi. 10.1684/hma.2018.1362
- By:
- Publication type:
- Article
Lymphocytes NK : un rôle majeur dans le contrôle immunologique de la leucémie myéloïde chronique.
- Published in:
- Médecine Sciences, 2018, v. 34, n. 6/7, p. 540, doi. 10.1051/medsci/20183406013
- By:
- Publication type:
- Article
Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
- Published in:
- 2020
- By:
- Publication type:
- case study
Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.
- Published in:
- 2007
- By:
- Publication type:
- journal article